# Asensus Surgical: company

Canonical ID: `a3a097cb-a5db-4ffd-b421-5eb14335dbcf`

## Key facts

- **Product:** Senhance laparoscopic robot (FDA 510(k) Oct 2017); LUNA next-gen (uncleared).
- **Acquisition:** Karl Storz, closed Aug 22 2024, $0.35/sh ~$95M; delisted.

- **Slug:** asensus-surgical
- **Status:** acquired by Karl Storz (Aug 2024; ~$95M; delisted)
- **Founded:** 2006
- **HQ:** Durham, North Carolina, USA

## Models

- [Senhance](/models/asensus-senhance.md) (surgical) (id: `abadf566-b528-4b44-be3e-418ca078e920`)

## Supplies to

_No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this company's outbound edges._

_Outbound supply edges. Each appears when verified with at least two strong sources. Sources are append-only; corrections add new sources rather than rewrite history._

## Sources (4)

1. https://www.globenewswire.com/news-release/2024/08/22/asensus-surgical-karl-storz-closing
2. https://www.massdevice.com/asensus-surgical-karl-storz-acquisition/
3. https://www.urologytimes.com/view/transenterix-senhance-fda-clearance
4. https://www.therobotreport.com/karl-storz-closes-acquisition-of-asensus-surgical/

_API: GET /v1/companies/a3a097cb-a5db-4ffd-b421-5eb14335dbcf · canonical URL: /companies/asensus-surgical_